Guizhou Yibai Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Yibai Pharmaceutical Co., Ltd. with three other
companies in this sector in CHINA :
Heilongjiang ZBD Pharmaceutical Co Ltd
sales of 3.29 billion Chinese Renmimbi [US$464.86 million]
of which 62%
was Pharmaceutical Industry),
Chengdu Kanghong Pharmaceutical Group Co Ltd
(3.26 billion Chinese Renmimbi [US$459.98 million]
of which 100%
was Pharmaceutical Manufacturing), and
Anhui Fengyuan Pharmaceutical
(3.24 billion Chinese Renmimbi [US$457.28 million]
of which 51%
was Medicine Manufacturing).
During the year ended December of 2019, sales at
Guizhou Yibai Pharmaceutical Co., Ltd. were 3.36 billion Chinese Renmimbi (US$474.64 million).
decrease of 13.4%
versus 2018, when the company's sales were 3.88 billion Chinese Renmimbi.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Guizhou Yibai Pharmaceutical Co., Ltd. had sales
of 3.16 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 38.1% decline
in Medical Service, from 879.77 million Chinese Renmimbi to 544.75 million Chinese Renmimbi.
There were also decreases in sales in
Medical Industry (down 6.3% to 2.80 billion Chinese Renmimbi)